What The Sumaira Foundation does

The Sumaira Foundation (TSF) is a patient-led, science-driven 501(c)(3) nonprofit organization founded in 2014 by Sumaira Ahmed following her diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD). Headquartered in Brookline, Massachusetts, the organization is dedicated to raising global awareness of rare neuroimmune conditions — primarily NMOSD, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Myasthenia Gravis (MG) — and operates support, education, research, and advocacy programs serving patients, caregivers, and clinicians across multiple continents. Core offerings include patient education resources (brochures, diagnostic criteria documents, therapy charts, podcasts such as Demystifying NMO & MOG, and the "From the Experts" webinar series), community programs (the Human Collective Project support groups, Mental Health Mondays, caregiver support, Patient Days at institutions such as Mayo Clinic, Brigham and Women's, Massachusetts General, Oxford, and Charité Berlin), research funding (TSF-funded grants, fellowships, journal publications, and the Global Rare Trailblazer Award), advocacy tools (Brain Health Report, insurance navigation guides, shared decision-making guides), and financial assistance programs for affected patients and families.

TSF is not a technology product company and does not develop proprietary technology platforms. Its operational backbone is a global ambassador network, an international Medical Advisory Board, and multi-channel awareness infrastructure spanning seven social media platforms, podcasts, events, and earned media coverage in outlets such as CNBC, Neurology Live, Brain & Life Magazine, and Financial Times. Revenue is generated through a mix of tax-deductible individual donations, corporate sponsorships from rare neuroimmune pharma companies (Alexion/AstraZeneca Rare Disease, Amgen, argenx, Genentech, Roche, UCB, Johnson & Johnson, EUROIMMUN, Portal Instruments), merchandise sales via Bonfire and Square e-commerce storefronts, and the AmazonSmile affiliate program. The organization holds 501(c)(3) tax-exempt status (Charitable ID#: 47-2398246) and is governed by an independent Board of Directors.

TSF has scaled from a local Boston-based initiative to an international advocacy platform through a combination of organic program expansion and inorganic moves, including the August 2022 acquisition of the Connor B. Judge Foundation, the February 2023 launch of TSF France, and a June 2026 real-world data partnership with Citizen Health. It operates an international Medical Advisory Board including experts from Mayo Clinic and Korle-Bu Teaching Hospital in Ghana, and maintains global reach across North America, Europe, Asia, South America, and Africa.

Name

The Sumaira Foundation

Legal name

The Sumaira Foundation, Inc.

Website

https://sumairafoundation.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

The Sumaira Foundation is a patient-led 501(c)(3) nonprofit founded in 2014 that raises global awareness of rare neuroimmune conditions including NMOSD, MOGAD, and Myasthenia Gravis, serving patients, caregivers, clinicians, and researchers across multiple continents through education, support, research funding, and advocacy programs.

Ownership category

akta.pro rank

Product category

Patient Advocacy Services

NAICS

Voluntary Health Organizations (813212), Other Individual and Family Services (624190)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Social Services (8300)

akta.pro primary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

akta.pro secondary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Rare disease advocacy
• Patient support services
• Neuroimmune disease awareness
• Medical research funding
• Patient education resources

Headquarters

HQ city

Brookline

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: Tax-deductible donations from individuals supporting rare neuroimmune disease awareness and research. The organization is a 501(c)(3) tax-exempt organization with Charitable ID#: 47-2398246.
2. Corporate Sponsorships and Industry Partnerships: Funding and support from pharmaceutical companies including Alexion, Amgen, argenx, AstraZeneca, Genentech, Roche, UCB, and others who partner with the foundation for patient advocacy initiatives.
3. Merchandise Sales: Sales of merchandise through Bonfire store and Square e-commerce site, including Unicorns products and branded items.
4. AmazonSmile Program: Amazon donates 0.5% of eligible purchases when customers select The Sumaira Foundation as their charitable organization.

Distribution channels4 records

Marketing channels8 records

Core offering

The Sumaira Foundation is a 501(c)(3) nonprofit that delivers awareness, education, support, advocacy, and research funding programs for patients with rare neuroimmune conditions, specifically Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Myasthenia Gravis (MG). It operates support groups (Human Collective Project), caregiver programs, mental health resources, financial assistance, fellowships and funded research, global ambassador communities, and branded merchandise, alongside partnerships with pharmaceutical companies and academic medical centers.

Product overview

The Sumaira Foundation (TSF) is a patient-led 501(c)(3) nonprofit organization dedicated to raising awareness of rare neuroimmune conditions, specifically NMOSD (Neuromyelitis Optica Spectrum Disorder), MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease), and Myasthenia Gravis. The foundation operates as a resource and support organization rather than a technology product company. Its offerings include patient education and support programs (Human Collective Project support groups, Mental Health Mondays, caregiver support), research funding and fellowships, global ambassador networks, financial assistance programs, advocacy resources, educational brochures, and community events. The organization connects patients with resources, funds research initiatives, and builds global communities through ambassador programs and awareness campaigns.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Education and Support Programs Comprehensive support services including support groups (Human Collective Project), Mental Health Mondays, caregiver support groups, patient stories (Voices of TSF), and patient days for individuals with NMOSD, MOGAD, and MG.
• Research Funding and Fellowships TSF-funded research grants, fellowships for researchers, journal publications, research summaries, and the Global Rare Trailblazer Award recognizing contributions to rare disease research.
• Financial Assistance Programs Assistance programs providing financial support to patients and caregivers affected by rare neuroimmune diseases.
• Global Ambassador Program Network of TSF ambassadors representing the foundation globally across multiple continents, languages, and communities to support patients and caregivers.
• Events and Community Gatherings Calendar of events including patient days, support group meetings, fundraising events, educational webinars, and awareness campaigns across multiple countries.
• TSF Merchandise (Unicorns Shop) Online merchandise store featuring unicorn-themed items representing the foundation's symbol, available through the Bonfire store and Square Unicorns shop.
• Educational Brochures and Infographics Patient education brochures on understanding NMOSD and MOGAD, research infographics, and accessible informational materials available for ordering.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered core, major and minor.

• Citizen HealthcoreStrategic or Co-development Partner · 1 June 2026The Sumaira Foundation selected Citizen Health as its real-world data partner in June 2026. This partnership supports TSF's research initiatives by providing access to real-world patient data for rare neuroimmune disease research.
• AlexionmajorGTM or Marketing PartnerAlexion, AstraZeneca Rare Disease, is an industry partner supporting TSF's awareness and advocacy initiatives for NMOSD and MOGAD patients. Alexion has been featured in TSF's media coverage and patient engagement activities.
• AmgenmajorGTM or Marketing PartnerAmgen is an industry partner supporting rare neuroimmune disease awareness. Featured in TSF's storytelling and advocacy efforts, including coverage of founder Sumaira Ahmed's journey.
• argenxmajorGTM or Marketing Partnerargenx is an industry partner supporting TSF's mission for rare neuroimmune disease awareness and patient advocacy.
• AstraZenecamajorGTM or Marketing PartnerAstraZeneca, through its Rare Disease division (Alexion), partners with TSF to support awareness, advocacy, and patient resources for NMOSD and related conditions.
• EUROIMMUNminorGTM or Marketing PartnerEUROIMMUN is an industry partner contributing to TSF's awareness initiatives, including educational content about MOGAD.
• GenentechmajorGTM or Marketing PartnerGenentech is a long-standing industry partner that has featured TSF founder Sumaira Ahmed in patient advocacy content and supports community building initiatives.
• Johnson & JohnsonmajorGTM or Marketing PartnerJohnson & Johnson is an industry partner supporting TSF's rare neuroimmune disease awareness and advocacy efforts.
• Portal InstrumentsminorGTM or Marketing PartnerPortal Instruments partnered with The Sumaira Foundation in March 2021 to support NMO patient communities.
• RochemajorGTM or Marketing PartnerRoche is an industry partner supporting TSF's rare neuroimmune disease advocacy and awareness initiatives.
• UCBmajorGTM or Marketing PartnerUCB is an industry partner supporting TSF's mission to raise awareness and provide support for rare neuroimmune conditions.
• Connor B. Judge FoundationcoreStrategic or Co-development PartnerIn August 2022, The Sumaira Foundation announced the acquisition of the Connor B. Judge Foundation, expanding its reach and resources for the rare neuroimmune disease community.
• The Transverse Myelitis AssociationmajorStrategic or Co-development PartnerThe Transverse Myelitis Association (TMA) announced its partnership with TSF in October 2018, combining resources and advocacy efforts for rare neuroimmune conditions.
• Guthy-Jackson Charitable FoundationmajorStrategic or Co-development PartnerGuthy-Jackson Charitable Foundation is acknowledged as a partner supporting New England NMO Patient Day events and collaboration with TSF.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Others

• Alexion / AstraZeneca Rare Disease: Major TSF industry partner and developer of Soliris/Ultomiris for NMOSD. Comparable patient community engagement programming and overlapping rare-neuroimmune therapeutic focus; partner-ecosystem comparable rather than direct competitor.
• Rare Diseases Clinical Research Network: NIH-funded consortium that conducts collaborative clinical research on rare diseases. Functions as a research infrastructure peer and potential research-funding collaborator for TSF's fellowship and grants programs.

Broad incumbents

• National Organization for Rare Disorders (NORD): Umbrella advocacy organization for the broader rare disease community. Larger scale, broader portfolio of conditions; serves as a complement to TSF's narrow NMOSD/MOGAD/MG focus and competes for the same pharma partnership dollars.
• Global Genes: Allied rare-disease advocacy and patient empowerment organization. Comparable awareness, education, and community-building mission but at a broader scale and with a wider disease portfolio.

Direct peers

• Guthy-Jackson Charitable Foundation: The most direct peer — a charitable foundation singularly focused on NMO/NMOSD, co-hosts New England NMO Patient Day with TSF. Comparable mission, patient population, and pharma sponsor mix.
• Myasthenia Gravis Foundation of America: National voluntary health organization dedicated to Myasthenia Gravis — directly overlapping one of TSF's three disease pillars. Similar revenue model (donations, pharma sponsorships) and comparable research-funding and patient-support programs.
• The Transverse Myelitis Association: Long-standing TSF partner (since 2018) and peer organization serving rare neuroimmune conditions including transverse myelitis and related disorders. Overlapping patient community and similar awareness/advocacy programming.

Emerging players

• Concussion Legacy Foundation: Patient-led, science-driven advocacy organization with a comparable operating playbook (founder-led, research funding, awareness campaigns, global ambassador model), focused on a different but adjacent brain-injury patient population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/TheSumairaFDN
• YouTubeyoutube.com/channel/UCuEBn83jkjD3ncGH_gOJ9YA
• Facebookfacebook.com/TheSumairaFoundation
• LinkedInlinkedin.com/company/the-sumaira-foundation-inc-
• Instagraminstagram.com/thesumairafoundation
• TikToktiktok.com/@thesumairafoundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Sumaira Foundation